Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
about
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostPoliovirus cell entry: common structural themes in viral cell entry pathwaysCrystal structure of CD155 and electron microscopic studies of its complexes with poliovirusesAntibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralizationCryo-EM of viruses and vaccine designViral entry pathways: the example of common cold virusesViral quasispecies evolutionPrinciples of virus structural organizationInteraction of the poliovirus receptor with poliovirusInteraction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptorCrystal Structure of Swine Vesicular Disease Virus and Implications for Host AdaptationStructure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory AntibodyDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityHigh-Resolution X-Ray Structure and Functional Analysis of the Murine Norovirus 1 Capsid Protein Protruding DomainStructural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01Cross-neutralization of influenza A viruses mediated by a single antibody loopConformational Shift of a Major Poliovirus Antigen Confirmed by Immuno-Cryogenic Electron MicroscopyStructure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20Flexibility in Surface-Exposed Loops in a Virus Capsid Mediates Escape from Antibody NeutralizationAdding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron MicrographsVL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructsAntibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexesTopological mimicry and epitope duplication in the guanylyl cyclase C receptor.Structure of a neutralizing antibody bound monovalently to human rhinovirus 2Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.HIV-1 and influenza antibodies: seeing antigens in new waysIdentification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation.Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.Engineering of single Ig superfamily domain of intercellular adhesion molecule 1 (ICAM-1) for native fold and function.Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody bindingVirus entry: molecular mechanisms and biomedical applications.Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.Diversity of core antigen epitopes of hepatitis B virusDifferent mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.Computational Identification of Antibody Epitopes on the Dengue Virus NS1 Protein.Antiviral antibody responses: the two extremes of a wide spectrum.Antiviral agent blocks breathing of the common cold virus.Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71.Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.Protein engineering strategies for the development of viral vaccines and immunotherapeutics.
P2860
Q23925011-A2191E6B-B7AF-44EC-8471-FC7A3D26EF26Q24550839-5A3C4AE7-7691-42EF-BB68-F703BA5C8762Q24653737-32F045B1-B236-4785-BC69-43FCAE4AE21BQ24654597-CD7315E3-90A4-4D5F-BA94-3337431A57B4Q26250262-BB76FA94-FF58-46ED-80A5-E1C7E49DBB10Q26750146-701A3197-9A54-46F2-9B22-08EC0E3BD1EBQ27013917-1E993D64-6E9D-4013-B5EA-1382BC5821E1Q27021684-706F7836-BD3D-4ADE-886A-5BEAD64260C9Q27620834-E9200CD7-AB53-4F8F-BA12-48C0A1262C33Q27635031-A33CCF30-6833-4A80-9E68-2844E17DB777Q27640971-5AC24A5B-25C9-4195-9B50-8370CAAFF4F5Q27648686-0F21A945-F0F0-4D9B-8226-9A7D805AF503Q27654848-6A618816-A2FE-424D-95FD-0923E9CB678EQ27660321-DEF6F697-A405-45D2-A210-59C608799564Q27663293-E0AD06EE-B121-4ACC-85C8-D3E222EFC854Q27673206-7154D93A-2A7C-463E-AF7E-25F501D36815Q27678634-C7320236-AB01-4D21-85CE-DFB9B2DF6392Q27681034-01F550E5-0D6C-47E4-9A20-9C21CB9A99AFQ27681611-6E5E4E04-FF7C-4E2F-8251-0CE256A69242Q27702159-058EDDFC-E7F7-4C07-99BB-B2DB838DD85CQ27745669-667B98DA-79FC-46C2-A98B-3D61BA85E8ADQ27756974-C87E0A42-C174-4008-A2F2-C48A35543595Q31989458-D7756170-42C8-4892-91FB-A99C5BC843C5Q32066676-890756DF-EE9A-40B0-BBB5-C789839B6CA5Q33281854-72DC5D67-684A-4DC3-AE24-7CC8EBD130B9Q33552488-7F415E25-CA79-42F2-896B-121809018F1AQ33849272-CC0A4887-608E-4444-A09F-718896DCFA5EQ33850847-508D4E3A-9F9A-4DCB-9031-53E6FEDFCBB5Q33855145-269A225A-1D4E-49CC-9EA8-D52819B04BB7Q34996753-37EEA5DB-5987-4D9A-BCF3-A55DF8B42F0BQ35712985-F87462E6-67C8-45B6-AB91-306F6539B99AQ35861163-C4309EDD-740E-4296-8D40-158C99FB31A1Q35978599-74556994-7B47-4751-BFA5-563D59E26C10Q36009940-D560ADB8-AD5B-4CD4-9C28-5A805A5AAE0CQ36342001-29E1EEDB-9B45-40AB-B809-47A6CFA5D431Q36405084-8C70E7EE-F3CB-4B1A-93D0-E33E4C9C157BQ36489398-32384F8F-2E1E-4EAE-8B4A-8D7E3A56CB5EQ36651241-3AC1BAA0-BA43-4ABE-9127-1F7C4FCA42F6Q37410770-4111283E-40E0-4CAF-A600-D236276CFA25Q37625877-611481EB-AA4B-4A1D-AB8A-BDB9A3E6BFED
P2860
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@ast
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@en
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@nl
type
label
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@ast
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@en
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@nl
prefLabel
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@ast
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@en
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.
@nl
P2093
P2860
P356
P1433
P1476
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon
@en
P2093
P2860
P2888
P304
P356
10.1038/383350A0
P407
P577
1996-09-01T00:00:00Z
P5875
P6179
1018417165